Research Library

The safety and efficacy of many stem cell treatments remain unproven by the FDA, yet state laws promote access and use of these unchecked and potentially harmful treatments. Fellow Kirstin R.W. Matthews summarizes her recent publication in a new commentary — outlining public health consequences of these state laws and calling for scientific societies’ advocacy in state policymaking.

Although the media often portrays migration at the U.S.-Mexico border as a “crisis,” experts Kelsey Norman and Ana Martín Gil argue that this depiction lacks nuance and sidesteps possible solutions. This report provides a more realistic view of the situation and offers key policy recommendations.

What's behind the rise of U.S. manufacturers “nearshoring” to Mexico? In this report, fellow David A. Gantz explores the historical drivers fueling this trend and the reasons why Mexico may struggle to attract foreign investment in the near future.

The 2024 Mexico Country Outlook report analyzes key policy issues ahead of Mexico’s June 2024 elections, from foreign investment and regulatory challenges to migration and public security.

Legalizing recreational marijuana was intended to remedy the racially disparate effects of cannabis prohibition. But new research from our experts finds persistent racial disparities in the legal system’s practice of mandating treatment for cannabis use.

Progress on the UN’s sustainable development goals — aimed at achieving peace and prosperity for all people and the planet — has been slow. However, fellow Harris A. Eyre and his co-authors explain how applying a brain capital framework could change the trajectory.

The creation of a new industry of brain capital technologies could stimulate major economic activity, create jobs, and contribute to technological advances for the U.S. and its allies, write Harris Eyre, Rachel Meidl and co-authors.

Where do the GOP presidential hopefuls stand on major foreign policy issues? Bonner Means Baker Fellow Joe Barnes explores the Republican candidates’ likely policy approaches to the Ukraine war, Chinese expansionism, fentanyl at the border and more.

Under President Andrés Manuel López Obrador, Mexico is squandering a once-in-a-generation opportunity to encourage significant new foreign investment. His successor will need to reverse course, writes David A. Gantz, the Will Clayton Fellow in Trade and International Economics.

Decades of bad policy have heightened the risks of drug use and created barriers to treatment. And while some states are now trying to reduce the harms caused by the drug war, Texas is doubling down on ineffective policies.